Insight Molecular Diagnostics signals ~$8M quarterly cash burn in H2 2026 while targeting FDA authorization later this year
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
MOPH Announces Global Youth Competition on Influenza and COVID-19 Prevention
The Ministry of Public Health (MOPH) has announced the launch of the Global Youth Competition on Influenza and COVID-19 Prevention and Control, organised by the World Health Organization (WHO).
Parents threaten school boycott over Mobile toilets, ‘We need R27 billion to fix schools’ – Education MEC
Health-e News Parents threaten school boycott over Mobile toilets, ‘We need R27 billion to fix schools’ – Education MEC As the Gauteng Education Department faces a R27 billion backlog in school…
Gland Pharma Share Price Surges 12% To Four-Year High After Strong Q1FY27 Results
Gland Pharma shares surged 12% on Tuesday, touching a more than four-year high of ₹2,989.25 on the BSE after the pharmaceutical company reported strong financial results for the June 2026 quarter.
Trump signs order to reduce childhood vaccines and break up MMR shots
The revised vaccination schedule recommends immunising children against 11 diseases, six fewer than currently recommended.
Nigeria: Health Advocates Reject Easing of Advertising Restrictions in Tobacco Bill
[Daily Trust] The Nigeria Tobacco Control Alliance (NTCA) has called on the National Assembly to immediately recall the National Tobacco Control Act (Amendment) Bill 2025 and subject it to a…
‘Drops take seconds but change a life for ever’: the women saving India’s remotest people from polio
Shameema and Tanzeela must trek for miles in summer heat to vaccinate children in Kashmir’s highlands as part of a vast national programme Before sunrise, Shameema slips on her worn rubber sandals and…